Same Indication

Muromonab-Cd3 vs Pembrolizumab

Muromonab-Cd3 vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Muromonab-Cd3 and Pembrolizumab.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days.

Chemical Properties

Type: Muromonab-Cd3 — Unknown; Pembrolizumab — Antibody.